...
首页> 外文期刊>Surgery Today >Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery
【24h】

Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery

机译:奥沙利铂和分子靶向药物治疗改善了进行不完全细胞还原手术的同步腹膜癌大肠癌患者的总体生存率

获取原文
获取原文并翻译 | 示例

摘要

Purpose To estimate the feasibility and limitations of incomplete cytoreductive surgery and modern systemic chemotherapy in patients with synchronous peritoneal carcinomatosis from colorectal cancer and to identify risk factors for death and factors associated with the patient prognosis.
机译:目的评估不完全细胞还原术和现代全身化学疗法在大肠癌并发性腹膜癌患者中的可行性和局限性,并确定死亡危险因素和与患者预后相关的因素。

著录项

  • 来源
    《Surgery Today 》 |2015年第8期| 986-992| 共7页
  • 作者单位

    Department of Gastroenterological and Transplant Surgery Applied Life Sciences Institute of Biomedical and Health Sciences Hiroshima University">(1);

    Department of Gastroenterological and Transplant Surgery Applied Life Sciences Institute of Biomedical and Health Sciences Hiroshima University">(1);

    Department of Gastroenterological and Transplant Surgery Applied Life Sciences Institute of Biomedical and Health Sciences Hiroshima University">(1);

    Department of Gastroenterological and Transplant Surgery Applied Life Sciences Institute of Biomedical and Health Sciences Hiroshima University">(1);

    Department of Gastroenterological and Transplant Surgery Applied Life Sciences Institute of Biomedical and Health Sciences Hiroshima University">(1);

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Colorectal cancer; Peritonial carcinomatosis; Synchronous;

    机译:大肠癌;腹膜癌变;同步;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号